BRIEF published on 07/18/2024 at 16:05, 1 year 4 months ago Phoenix Specialty Mfg. Co. Appoints Elizabeth Bunch as Chief Financial Officer Financial Management CFO Appointment Manufacturing Phoenix Specialty Elizabeth Bunch
BRIEF published on 07/18/2024 at 16:05, 1 year 4 months ago Phoenix Specialty Mfg. Co. nomme Elizabeth Bunch au poste de directrice financière Direction Financière Nomination Du Directeur Financier Fabrication Spécialité Phénix Elizabeth Bouquet
PRESS RELEASE published on 07/18/2024 at 16:00, 1 year 4 months ago Phoenix Specialty Mfg. Co. Appoints Elizabeth Bunch as Chief Financial Officer Phoenix Specialty Mfg. Co. appoints Elizabeth Bunch as CFO, bringing a wealth of financial management experience. Her leadership and vision aim to drive the company forward Financial Management CFO Manufacturing Industry Elizabeth Bunch Phoenix Specialty Mfg. Co.
Published on 12/05/2025 at 02:35, 4 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 26 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 11 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
